LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 49.63 | 27.76 | 1033 | 4818 | 0.2144 | 0.6261 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 49.63 | 27.76 | 1093 | 4818 | 0.2269 | 0.6384 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 49.63 | 27.76 | 1108 | 4818 | 0.2300 | 0.6414 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 51.33 | 27.76 | 973 | 5117 | 0.1902 | 0.6042 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 51.33 | 27.76 | 1033 | 5117 | 0.2019 | 0.6170 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 51.33 | 27.76 | 1115 | 5117 | 0.2179 | 0.6335 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 51.33 | 27.76 | 1128 | 5117 | 0.2204 | 0.6360 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 53.04 | 27.76 | 974 | 5365 | 0.1815 | 0.5975 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 53.04 | 27.76 | 1029 | 5365 | 0.1918 | 0.6091 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 53.04 | 27.76 | 1092 | 5365 | 0.2035 | 0.6218 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 53.04 | 27.76 | 1108 | 5365 | 0.2065 | 0.6249 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 54.74 | 27.76 | 983 | 5606 | 0.1753 | 0.5933 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 54.74 | 27.76 | 1039 | 5606 | 0.1853 | 0.6049 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 54.74 | 27.76 | 1120 | 5606 | 0.1998 | 0.6207 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 54.74 | 27.76 | 1148 | 5606 | 0.2048 | 0.6259 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 56.45 | 27.76 | 952 | 5745 | 0.1657 | 0.5833 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 56.45 | 27.76 | 1033 | 5745 | 0.1798 | 0.6002 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 56.45 | 27.76 | 1121 | 5745 | 0.1951 | 0.6173 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 56.45 | 27.76 | 1153 | 5745 | 0.2007 | 0.6232 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 58.15 | 27.76 | 930 | 5906 | 0.1575 | 0.5748 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 58.15 | 27.76 | 1014 | 5906 | 0.1717 | 0.5925 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 58.15 | 27.76 | 1107 | 5906 | 0.1874 | 0.6106 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 58.15 | 27.76 | 1135 | 5906 | 0.1922 | 0.6158 | MN20160318_Q01 | I08 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 59.85 | 27.76 | 985 | 6062 | 0.1625 | 0.5830 | MN20160318_Q01 | C10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 59.85 | 27.76 | 1039 | 6062 | 0.1714 | 0.5939 | MN20160318_Q01 | C10 |